ArticleJournal of Crohn's & colitis2025

A multicenter study of the real-world effectiveness and safety of risankizumab in Crohn's disease.

Amanda M Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.